Clinical Trial: Dose Reduction and Discontinuation With Anti-Fibrotic Medications
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Idiopathic Pulmonary Fibrosis
Study Type: OBSERVATIONAL
Official Title: Assessment of the Dose Reduction and Discontinuation Associated With Anti-Fibrotic Medications in Patients With Idiopathic Pulmonary Fibrosis
Brief Summary:
The overarching aim of our study is to assess the incidence of dose reduction and discontinuations for pirfenidone and nintedanib.
Read more